Registration and setting up the posters 



Welcome Session  

  João Nuno Moreira (CNC/UC, FFUC, President of the SPLC-CRS), Luís Menezes (Vice-Dean of the University of Coimbra)María José Alonso ("President elect" of the Controlled Release Society)


 Plenary Lecture 

 Nicholas A PeppasProtein, Antibody and siRNA Delivery Using Intelligent Polymers with Molecular Recognition Capabilities

 Sc.D. Cockrell Family Regents Chair in Engineering, Department of Biomedical Engineering, McKetta Department of Chemical Engineering,  Department of Pediatrics, Department of Surgery and Perioperative Care, Dell Medical School, Division of Pharmaceutics, College of Pharmacy  Director, Institute for Biomaterials, Drug Delivery and Regenerative Medicine The University of Texas at Austin, USA


 Session Chair - María José Alonso (CIMUS Research Institute, University Santiago de Compostela)


SESSION 1 - Neurological disorders

 Session Chair  - Alicia Rodriguez Gascón (University of the Basque Country, Vitoria)


 Ana Paula Pêgo -  Engineering Nanoparticles to Cargo Nucleic Acids to the Nervous System: Breaking Barriers with Nanotools

 INEB - Instituto de Engenharia Biomédica and i3S - Instituto de Investigação e Inovação em Saúde, University of Porto


 Elisa Garbayo Atienza -  Brain regeneration in Parkinson's disease using micro/nanoparticles

 Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy,  University of Navarra, Spain


 Luís Pereira de Almeida - Non-invasive gene therapy of the brain 

 Center for Neurosciences and Cell Biology; Faculty of Pharmacy, University of Coimbra, Portugal


SESSION 2 - PhD Thesis Award 

 Session Chair - Dolores Torres (Vice-President of the SPLC-CRS) 


 Award Announcement and Thesis Presentation


Welcome Cocktail: Passaporte - Lounge Terrace, Rua da Couraça Estrela, Coimbra (as in Google Maps).


 Plenary Lecture 

 Patrick Couvreur - Nanomedicines for the treatment of cancer and neurological disorders  

 Member of the Académie des Sciences, Institut Galien Paris-Sud, UMR CNRS 8612, Université Paris-Sud, Université Paris Saclay, Châtenay-  Malabry Cedex, France 


SESSION 3 - Cancer

  Session Chair - António Almeida (Faculty of Pharmacy, University of Lisbon)


 Davide Prosperi  - Impact of ligand moiety on targeting and anti-tumor effect of antibody nanoconjugates

 Department of Biotechnology and Biosciences, University of Milano Bicocca, Italy


 Maria Jesus Vicent - Towards the Design of Personalised Polymer-based Combination Conjugates for Advanced Stage Breast Cancer Patients

 Centro de Investigación Príncipe Felipe, Valencia, Spain


  António Duarte  - Targeting Notch signaling in mouse tumor models

 Faculdade de Medicina Veterinária, Universidade de Lisboa

 11.15 - 11.45

 Coffee-break and Speed Dating with Bluepharma 


SESSION 4 - SPLC-CRS Young Section

 Session Chair - Simón Pascual-Gil (University of Navarra) and Pedro Fonte (Lusófona University, Lisbon)

 11.45 - 13.10

 Short Talks Selected from Abstracts *

  • 11.45 - 11.52 - Eugénia Nogueira, Folate-targeted liposomes for rheumatoid arthritis therapy. Centre of Biological Engineering, University of Minho, Braga, Portugal.
  • 11.52 - 11-59 - Jacinta PinhoTargeting AQP3 using a nanotechnological approach for melanoma treatment. Research Institute for Medicines, Faculty of Pharmacy,      Universidade de Lisboa.
  • 11.59 - 12-06 - Ainhoa Gonzalez-PujanaMatrix-mediated gene expression regulation in mesenchymal stem cells immobilized in alginate-poly-L-lysine-alginate         microcapsules. School of Pharmacy, University of the Basque Country, Vitoria
  • 12.06 - 12.13 - Edorta Santos-VizcainoUse of genipin as a quantitative imaging biomarker in implanted immunoisolation devices. School of Pharmacy, University of   the Basque Country, Vitoria.
  • 12.13 - 12.20 - João ConniotCombination of Dendritic Cell-targeted Nano-vaccines with Immune Checkpoint Therapy for Melanoma. Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa.
  • 12.20 - 12.27 - Laura SaludasEnhanced biological functions of adipose derived stem cells in the injured myocardium of a rat myocardial infarction model when     combined with neuregulin-loaded microparticles. Faculty of Pharmacy, University of Navarra, Pamplona.
  • 12.27 - 12.34 - Iago Fernández-MariñoInteraction of small and medium size chitosan nanocapsules with different subsets of immune cells. Center for Research in     Molecular Medicine and Chronic Diseases, University of Santiago de Compostela.
  • 12.34 - 12.41 - Duy-Khiet HoSqualenyl Hydrogen Sulfate Nanocarrier for Dual-Delivery of Anti-infective Quorum Sensing Inhibitor and Aminoglycoside Antibiotic   Tobramycin. Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken.
  • 12.41 -12.48 - Josephine BlerschHT-Screening identifies light triggerable NP formulation for efficient in vivo non-coding RNA delivery in wound healing. Center for Neuroscience and Cell Biology, University of Coimbra.
  • 12.48 - 12.55 - Branca SilvaOrodispersible films to treat a neurodegenerative disorder: clinical proof of concept. Bluepharma Indústria Farmacêutica and Faculty of Pharmacy, University of Coimbra.
  • 12.55-13.02 - Nuno FonsecaTumor intracellular bioavailability of doxorubicin determines therapeutic efficacy of GLP grade nanoparticle targeted to nucleolin independently of systemic exposure. Center for Neuroscience and Cell Biology, University of Coimbra.
  • 13.02 - 13.09 - Patrícia AlbuquerqueExosomes: tiny vesicles with great potential for MJD treatment. Center for Neuroscience and Cell Biology, University of Coimbra.

 Lunch and Speed Dating with Bluepharma 


 SESSION 5 - Poster Discussion **


 SESSION 6 - Regenerative Medicine 

  Session Chair - Gorka Orive Arroyo (University of the Basque Country, Vitoria)


  Lino Ferreira - Drug Delivery in Regenerative Medicine 

 Faculty of Medicine, Center for Neuroscience and Cell Biology, University of Coimbra, Portugal


 Marcos Garcia Fuentes - mRNA-activated reprogramming matrices

 Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, Spain 


 Nuno Neves - Highly Functional Nanostructured Surfaces and Devices for the Development of Effective Tissue Engineering Strategies.
3B’s Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and   Regenerative Medicine, AvePark, Taipas, Guimarães. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães.


 Coffee-break and Speed Dating with Bluepharma  


 SESSION 7 -  Diagnosis / Medical Devices 

 Session Chair -  Ana Grenha (Faculdade de Ciências e Tecnologia, Universidade do Algarve)


 Pedro Viana Baptista  - Versatile gold nanoparticles for molecular diagnostics in leukemia

  Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus Caparica, Portugal


 Manuel Arruebo  - Near infrared dye-labeled polymeric micro- and nanomaterials: in vivo imaging and evaluation of their local persistence 

  Aragon Nanoscience Institute, University of Zaragoza, Spain 




CONFERENCE DINNER: Quinta das Lágrimas Hotel, Rua António Augusto Gonçalves., Coimbra (as in Google Maps). Buses will be available and will depart from Hotels Tivoli, Tryp Coimbra and IBIS at 8.30 pm.


SESSION 8 -  Immunotherapy

 Session Chair - Olga Borges (CNC & Faculty of Pharmacy, University of Coimbra)


 João Gonçalves  - Antibody engineering strategies for antiviral neutralization 

 Research Institute for Medicines, iMed.ULisboa, Faculty of Pharmacy, University of Lisbon, Portugal


 Miguel Prudêncio  - Towards clinical evaluation of a new malaria vaccine

 Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon


 Helena Florindo  -  Enhancing cancer immunotherapy via nanotechnology-based strategies to engage innate and adaptive immune responses                            

 Research Institute for Medicines, iMed.ULisboa, Faculty of Pharmacy, University of Lisbon, Portugal 


Coffee-break and Speed Dating with Blueclinical


SESSION 9 -  ROUND TABLE - Bridging the Translational Gap Between Academia and the Patient

 Session Chair - Rogério Gaspar   Faculty of Pharmacy  & Institute for Bioengineering and Biosciences, University of Lisbon, Portugal


 Laura Alho - Technology Transfer Office, University of Coimbra, Portugal 

 Cláudia Silva -  Bluepharma Indústria Farmacêutica SA and Luzitin, SA, Portugal

 Ricardo Cunha Blueclinical, Ltd, Portugal.

 David Cristina - Senior Investment Director, FOSUN.


Oral and Poster Communication Prizes

Concluding Remarks

* - ORAL COMMUNICATIONS in the SPLC-CRS Young Section, SESSION 4, are strictly limited to 5 min, with 2 min for Q&A


The posters selected by the scientific committee will be displayed for all the conference.

Your poster number will appear on the top right hand side of the board so you can locate your board easily.

Please check your poster number in the Abstract Book closer to the conference.

It is appreciated that a photo is shown (on the top of the poster)

Poster Discussion - SESSION 5

Authors are requested to be available for questions during the scheduled poster discussion.

It is desirable to provide takeaway versions of the poster in A4 format.

Poster Guidelines -  Poster must have the size of a standard (80cm x 118 cm) in portrait layout .